Public funding highlights
Public funding highlights
Selected developments and initiatives in 2Q19 from major sources of public funding including National Institutes of Health (NIH), the U.K.’s Medical Research Council (MRC), the Innovative Medicines Initiative (IMI), the Canadian Institutes of Health Research (CIHR), the Agency for Science Technology and Research (A*STAR) and the Japan Agency for Medical Research and Development (AMED).
| Date | Agency | Summary | Type |
|---|---|---|---|
| Apr. 11 | IMI | For its June calls for proposals, IMI announced it will focus on CAR T cell development and other curative cell and gene therapies, AI for pathology, patient access to healthcare information and patient outcome data. The total budget is €45 million ($49.5 million), with half coming from Horizon 2020 and half from |
